Qiang Fu

Qiang Fu


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2022 in Bioactive Materials
Verified
Journal Article
Open access
DLDawei Li
Dawei Li
GTGuoke Tang
Guoke Tang
HYHui Yao
Hui Yao
YZYuqi Zhu
Yuqi Zhu
CSChanggui Shi
Changgui Shi
Xing WangXing Wang
Xing Wang
In the current global crisis of antibiotic resistance, delivery systems are emerging to combat resistant bacteria in a more efficient manner. Despite the significant advances of antibiotic nanocarriers, many challenges like poor biocompatibility, premature drug release, suboptimal targeting to infection sites and short blood circulation time are still challenging. To achieve targeted drug delivery and enhance antibacterial activity, here we reported a kind of pH-responsive nanoparticles by simply self-assembly of an amphiphilic poly(ethylene glycol)-Schiff-vancomycin (PEG-Schiff-Van) prodrug and free Van in one drug delivery system. The acid-liable Schiff base furnished the PEG-Schiff-Van@Van with good storage stability in the neutral environment and susceptible disassembly in response to faintly acidic condition. Notably, on account of the combination of physical encapsulation and chemical conjugation of vancomycin, these nanocarriers with favorable biocompatibility and high drug loading capacity displayed a programmed drug release behavior, which was capable of rapidly reaching high drug concentration to effectively kill the bacteria at an early period and continuously exerting an bacteria-sensitive effect whenever needed over a long period. In addition, more Schiff-base moieties within the PEG-Schiff-Van@Van nanocarriers may also make great contributions on promoting the antimicrobial activity. Using this strategy, this system was designed to have programmable structural destabilization and sequential drug release due to changes in pH that were synonymous with bacterial infection sites, thereby presenting prominent antibacterial therapy both in vitro and in vivo. This work represents a synergistic strategy on offering important guidance to rational design of multifunctional antimicrobial vehicles, which would be a promising class of antimicrobial materials for potential clinical translation.

1 January 2021 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
YWYuanhao Wang
Yuanhao Wang
DJDong Ji
Dong Ji
CLChaoyu Lei
Chaoyu Lei
YCYingfei Chen
Yingfei Chen
YQYuran Qiu
Yuran Qiu
SLShaoyong Lu
Shaoyong Lu
Ras undergoes interconversion between the active GTP-bound state and the inactive GDP-bound state. This GTPase cycle, which controls the activities of Ras, is accelerated by Ras GTPase-activating proteins (GAPs) and guanine nucleotide exchange factors (SOS). Oncogenic Ras mutations could affect the GTPase cycle and impair Ras functions. Additionally, Src-induced K-Ras Y32/64 dual phosphorylation has been reported to disrupt GTPase cycle and hinder Ras downstream signaling. However, the underlying mechanisms remain unclear. To address this, we performed molecular dynamics simulations (~30 μs in total) on unphosphorylated and phosphorylated K-Ras4B in GTP- and GDP-bound states, and on their complexes with GTPase cycle regulators (GAP and SOS) and the effector protein Raf. We found that K-Ras4B dual phosphorylation mainly alters the conformation at the nucleotide binding site and creates disorder at the catalytic site, resulting in the enlargement of GDP binding pocket and the retard of Ras-GTP intrinsic hydrolysis. We observed phosphorylation-induced shift in the distribution of Ras-GTP inactive-active sub-states and recognized potential druggable pockets in the phosphorylated Ras-GTP. Moreover, decreased catalytic competence or signal delivery abilities due to reduced binding affinities and/or distorted catalytic conformations of GAP, SOS and Raf were observed. In addition, the allosteric pathway from Ras/Raf interface to the distal Raf L4 loop was compromised by Ras phosphorylation. These results reveal the mechanisms by which phosphorylation influences the intrinsic or GAP/SOS catalyzed transformations between GTP- and GDP-bound states of Ras and its signal transduction to Raf. Our findings project Ras phosphorylation as a target for cancer drug discovery.

18 May 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YQYuran Qiu
Yuran Qiu
XYXiaolan Yin
Xiaolan Yin
XLXinyi Li
Xinyi Li
YWYuanhao Wang
Yuanhao Wang
QFQiang Fu
Qiang Fu
SLShaoyong Lu
Shaoyong Lu
Dual-targeting therapeutics by coadministration of allosteric and orthosteric drugs is drawing increased attention as a revolutionary strategy for overcoming the drug-resistance problems. It was further observed that the occupation of orthosteric sites by therapeutics agents has the potential to enhance allosteric ligand binding, which leads to improved potency of allosteric drugs. Epidermal growth factor receptor (EGFR), as one of the most critical anti-cancer targets belonging to the receptor tyrosine kinase family, represents a quintessential example. It was revealed that osimertinib, an ATP-competitive covalent EGFR inhibitor, remarkably enhanced the affinity of a recently developed allosteric inhibitor JBJ-04-125-02 for EGFRL858R/T790M. Here, we utilized extensive large-scale molecular dynamics simulations and the reversed allosteric communication to untangle the detailed molecular underpinning, in which occupation of osimertinib at the orthosteric site altered the overall conformational ensemble of EGFR mutant and reshaped the allosteric site via long-distance signaling. A unique intermediate state resembling the active conformation was identified, which was further stabilized by osimertinib loading. Based on the allosteric communication pathway, we predicted a novel allosteric site positioned around K867, E868, H893, and K960 within the intermediate state. Its correlation with the orthosteric site was validated by both structural and energetic analysis, and its low sequence conservation indicated the potential for selective targeting across the human kinome. Together, these findings not only provided a mechanistic basis for future clinical application of the dual-targeting therapeutics, but also explored an innovative perception of allosteric inhibition of tyrosine kinase signaling.

12 November 2013 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
HXHaidong Xu
Haidong Xu
QMQiang Mei
Qiang Mei
LSLuxia Shi
Luxia Shi
JLJiajia Lu
Jiajia Lu
JZJianning Zhao
Jianning Zhao
QFQiang Fu
Qiang Fu

1 February 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
XLXinyi Li
Xinyi Li
JDJinyuan Dai
Jinyuan Dai
DNDuan Ni
Duan Ni
XHXinheng He
Xinheng He
HZHao Zhang
Hao Zhang
SLShaoyong Lu
Shaoyong Lu

26 July 2024 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
LDLanlan Dong
Lanlan Dong
RJRu Jia
Ru Jia
ZLZhong Liu
Zhong Liu
WAWurikaixi Aiyiti
Wurikaixi Aiyiti
CSCijun Shuai
Cijun Shuai
XLXiang Li
Xiang Li